Kedu ihe kpatara nnyefe Peptide ọnụ ji na-agabiga molekul n'onwe ya

Ihe Ọrụ Nnyefe Na-adịbeghị anya Na-egosi n'ezie

Ngwunye cyclic Peptide Ọnụ ego pept Isi mmalite atọ setịpụrụ ntọala nke eziokwu, na onye nke ọ bụla na-akwụsị nke ọma obere nzọrọ bioavailability.

Chebe. Nke Ibe ngwaahịa Capsugel na-akọwa capsule enteric dị njikere iji HPMC na HPMC-AS polymers nwere mmechi nchekwa nke Coni-Snap., na-echebe API ndị nwere mmetụta acid na ikwe ka nnyefe eriri afọ ezubere iche. Nguzogide acid nke ekwuputara ruru pH 6.0, na capsule na-ewepụ mkpa mkpuchi mkpuchi post-ejuputa. Nke ahụ bụ nkọwapụta usoro onunu ogwu: ọ na-ekwu ebe e mere shei ahụ ka ọ dị ndụ, Ọ bụghị ihe na-eme peptide mgbe ahapụchara ya.

Bilayer capsules maka ebumnuche ileal. Nke Nchịkọta nke etiti ihe ọmụma Capsugel nke Millet et al., European Journal of Pharmaceutical Sciences 2026;224:107601, na-akọwa usoro na-ejikọta HPMC- na oyi akwa nke dị n'ime pululan nwere akwa ethylcellulose dị n'èzí nwere sodium alginate dị ka pore mbụ - njikwa mgbasa yana ọrụ na-anabata gburugburu ebe obibi n'otu ụdị usoro onunu ogwu.. Ọmụmụ ihe ahụ tụlere otú nhazi nhazi na mmepụta mmepụta ihe si emetụta nguzogide gastric, permeability, mgbawa na ntọhapụ, wee chọpụta mkpokọta alginate kpọmkwem na ọnọdụ ọgwụgwọ nke mepụtara profaịlụ mwepụta na-egbu oge dabara na ebumnuche anya ileum.. Ọ bụ usoro-na-nhazi usoro ọmụmụ ihe. Ọ naghị akọ na vivo absorption.

Nchedo GLP-1 okpukpu abụọ. Nke Akwụkwọ ihu n'ihu n'ụdị lipid gbakwunyere capsules enteric bụ peptide kachasị mkpa nke atọ ahụ. Ndị odee chepụtara GLP-1 analog exenatide dị ka ụzọ ion hydrophobic (HIP) n'ụdị nke dabere na lipid nwere ihe mgbakwunye na-eme ka mbelata, wee megharịa gelatin/HPMC-AS enteric capsules nke mezuru ihe ndị USP chọrọ igbu oge.. Shei capsule na-echebe megide ọnọdụ afọ; ụmụ irighiri mmiri lipid na-echebe megide protease nke eriri afọ. Ndị ode akwụkwọ kọwara nsonaazụ ya dị ka ihe akaebe in vitro nke echiche wee kwuo n'ụzọ doro anya na na vivo pharmacokinetic na ọmụmụ ọgwụ ọgwụ., ogologo kwụsie ike, na ogologo oge nhazi-ọrụ ndakọrịta capsule ka ga-arụ.

Gụọ ọnụ, atọ isi iyi na-ekpuchi atọ dị iche iche n'ígwé nke otu nsogbu - shei, matrix, na peptide-in-vehicle — ma ọ dịghị nke ọ bụla n'ime ha na-egosi na mma onu bioavailability. Nke ahụ bụ ohere ziri ezi iji banye na mkparịta ụka ime ọ bụla.

Ihe kpatara na usoro naanị ya enweghị ike ikpebi ike ọnụ

A 2026 Ntụle ihu ihu nke mgbochi peptide ọnụ na-ekwu okwu ikpe physicochemical nke ọma: peptides dịtụ ukwuu, polar na ebubo, nke na-emepụta permeability dị ala site na akwa oyi akwa na epithelium dị n'okpuru; ha na-enwe ike ịnweta protease gastric na eriri afọ; ha na-agbakọta ọnụ; na ha na-adịkarịghị eguzosi ike n'ihe n'ụzọ na-agbagwoju anya siri ike usoro onunu ogwu ụdị mmepe. Nlebanya ahụ na-etinye bioavailability nke ọnụ maka ọtụtụ ogige dị n'okpuru 1%.

Njirimara ndị ahụ bụ eziokwu ọkwa usoro, ha na-agbasa. Ụgwọ net na nkesa chaja na-ekpebi ma peptide ọ ga-agafe netwọọkụ mucus na-adịghị mma ma ọ bụ kee ya. Hydrophobicity na-edobe njikọ nke akpụkpọ ahụ yana ihe ize ndụ nke mkpakọrịta onwe onye na nhazi-dị mkpa.. Motifs protease-susceptibility - saịtị ndị dị mkpa maka enzymes trypsin dị ka, Aroma residues maka chymotrypsin, N-terminal residues maka aminopeptidases - chọpụta nke enzymes luminal ga-ebu ụzọ buso ya agha yana ebe mgbanwe nkwụsi ike na-enweta kacha.. Mkpokọta propensity na-ekpebi ma itinye uche dị mkpa maka dosing bụ nke enwere ike iru na ụgbọ ala ahọpụtara.

Nke a bụ ya mere akwụkwọ nyocha dị ọcha enweghị ike idozi ike nke ọnụ. Ịdị ọcha HPLC bụ pasenti mpaghara ikwu; ọ na-agwa gị ole n'ime ihe ndị na-anabata UV bụ isi elu. Ọ naghị agwa gị ụdị mgbagha, mmiri fọdụrụnụ, ọdịnaya peptide net, ma ọ bụ ka molekul na-akpa àgwà mgbe ọ na-ezute gastric acid, bile salts na pancreatic enzymes n'usoro. A peptide nwere ike ịbụ 98% dị ọcha ma ka na-ada na mgbochi mbụ.

Nlebanya ahụ kọwakwara ihe kpatara na ubi ahụ akwụsịbeghị n'agbanyeghị sub-1% bioavailability. Mgbanwe nhazi nke na-ebuli ike, metabolic kwụsie ike na ọkara ndụ na-ekwe ka ọgwụgwọ mmetụta na ala otu-nọmba mkpughe. Oral semaglutide bụ ihe atụ guzobere; Ntụleghachi a na-ehotakwa macrocyclic PCSK9 inhibitor enlicitide na IL-23 antagonist icotrokinra dị ka oge ikpeazụ ma ọ bụ ikpe ịga nke ọma ụlọ ọgwụ., na Chugai's peptide cyclic Luna18, nke ruru 21%-47% bioavailability ọnụ n'ụdị preclinical. Ọnụ ụzọ ahụ kwagara n'ihi na e mere ya molekul ahụ - yana injinịa ahụ bụ mkpebi njikọ..

Ekwesịrị idobe nchekwa, Ọ bụghị Otu

Ọmụmụ GLP-1 nke agba abụọ kwesịrị ịgụ nke ọma n'ihi na ọ na-egosi na a kpachapụrụ anya n'ígwé ndị ahụ kama ịchọta ya na mberede..

Exenatide fọdụrụ mgbe 60 min na α-chymotrypsin (7.50 µg/ml, ụlọ okpomọkụ, HPLC ihe ndekọ). Unformulated exenatide wedara kpamkpam n'ime nkeji; ụzọ hydrophobic ion n'ụdị nke dabere na lipid ka edobere nke ọma 80%. Ihe dị iche n'etiti sodium caprate (C10) na ogwe aka mba-C10 abụghị ihe dị mkpa na ndekọ. In vitro proteolysis nchebe naanị - ọ bụghị permeability, absorption ma ọ bụ bioavailability. Isi mmalite: Dumont et al., N'ihu. Ọgwụ ọjọọ Deiv. 2026;6:1770094.

N'ọkwa molekul, ndị dere tụgharịrị exenatide acetate n'ime ụzọ ion hydrophobic. Ntụnye Log P si na -2.9 ± 0.3 maka acetate 0.1 ± 0.2 na 0.9 ± 0.2 maka SLS na DOC ion ụzọ abụọ na a 1:4 oke molar, na ụzọ DOC a na-ebuga n'ihu. Nke ahụ bụ mkpebi kemistri mere iji gbanwee omume nkewa nke molekul - ụdị nhọrọ nke dị na nhazi na usoro nhọrọ nnu., Ọ bụghị n'otu nhazi nke na-arụ ọrụ site na API edoziri.

Na ọkwa nhazi, A na-etinye HIP n'ime usoro nke dabeere na lipid na ihe ndị na-eme ka ọ dịkwuo mma. Usoro lipid na-arụ ọrụ abụọ: ọ na-eme ka peptide ghara ịkpakọrịta kpọmkwem na proteases nke eriri afọ, na ọ na-ejikọta peptide na ihe nkwalite permeation na elu epithelial. Nke ihe mgbochi nyochaa na-ekwu na imekọ ihe ọnụ bụ kpọmkwem ebe ọtụtụ ụdị usoro onunu ogwu na-ada - ma ọ bụrụ na ntọhapụ emee na ngalaba na-ezighi ezi., ma ọ bụ nhazi ahụ na-atụgharị, ma ọ bụ nkwalite kewapụrụ na API, ntụgharị asụsụ daa.

N'ọkwa usoro onunu ogwu, Capsule enteric ahaziri ahaziri na-enye nchebe gastric ma na-egbochi mmịnye akaghi aka nke usoro lipid na mmiri gastric., nke ga-ewepụ peptide na gburugburu ebe nchekwa ya. A na-ahazi mwepụta nke peptide na nkwalite na saịtị mmịpụta eriri afọ.

Ihe nleba anya kachasị na akwụkwọ a bụ nchọpụta nhazi nke na-apụta naanị mgbe peptide na ụgbọ ala na-amụkọ ọnụ.: nkwụsi ike dị mkpirikpi gosipụtara nbibi dabere na nhazi, na nhazi adịghị ọcha dị elu maka EXE-HIP solubilized karịa maka EXE acetate kwụsịtụrụ, karịsịa na ụlọ okpomọkụ. Ọnọdụ anụ ahụ nke API - ngwọta na nkwusioru - gbanwere ọnọdụ mmebi ahụ. Otu ndị mara naanị ntụ ntụ lyophilized gaara atụfu nke a kpamkpam, ma gaara achọpụta ya ma emechaa, na a ukwuu karịa ọnụ ogbo.

Ndị odee gosikwara ihe ize ndụ oxidation dabere n'usoro: methionine 14 na tryptophan 25 na-enwe ike ịnweta oxidation na lipid matrices nwere peroxides, aldehydes ma ọ bụ metal ion. Usoro voltammetry cyclic ha enweghị ike ịchọpụta antioxidant kacha dị irè, ya mere, ha na-akwado ihe mgbakwunye lipid ọhụrụ na njikwa ìhè na ikuku oxygen kama. Nke ahụ bụ ihe atụ doro anya nke njirimara usoro na-ebupụta usoro na njikwa ihe achọrọ.

Ntụle ọdụ-Ileum: Ihe kpatara saịtị na nfefe dị mkpa

Ebe distal bụ ebumnuche bara uru maka ihe ndị dị iche site na ụdị. Ọ bụ mpaghara absorption maka ụfọdụ ọgwụ na usoro na-apụta, gụnyere usoro ndu na usoro ọgwụgwọ nucleic acid, na nnyefe ezubere iche n'ebe ahụ nwere ike ịkwalite nrụpụta mpaghara ebe ọ na-ebelata mkpughe sistemu yana mmetụta ndị na-enweghị isi., dị ka Capsugel nchịkọta ndetu. Ọ na-ebukwa mkpokọta kacha elu nke patches Peyer, Nke a bụ ihe na-achọsi ike maka mgbochi nke mucosa, dị ka akwụkwọ akụkọ Nefecon imaging.

Ịkụ ya nke ọma bụ akụkụ siri ike. Mpaghara ahụ nwere gburugburu physiological na-agbanwe agbanwe yana obere oge nfefe dị mkpụmkpụ, na nchịkọta ahụ na-akọwapụta ntọhapụ a pụrụ ịdabere na ya n'ebe ahụ dịka otu n'ime ihe ịma aka kasịnụ fọdụrụ na nnyefe ọgwụ ọnụ.

Ihe nrịbama kachasị mma dị na-abịa site na nyocha onyonyo mmadụ nke capsule Nefecon, Mwepụta nke budesonide ezubere iche akwadoro maka isi IgA nephropathy nke na-eme ihe na-enweghị ụkọ IgA1 galactose na patches Peyer.. Ọmụmụ ihe ahụ jiri capsules ule na-emepụtagharị Nefecon na-egbu oge-nhapụ ọrụ, na caffeine dị ka akara maka oghere capsule (ọ na-apụta ngwa ngwa na mmiri mmiri mgbe ahapụchara ya) yana imaging resonance magnetik na ígwè oxide ojii iji chọta capsule ahụ wee jiri anya nke uche hụ mgbasa. Mgbasa in vitro gosipụtara na capsules ule dabara na njirimara ntọhapụ Nefecon. N'ime 10 nke 12 ndị ọrụ afọ ofufo ahụ meghere capsule n'ime anya ụlọum; na abụọ nke ọzọ ọ meghere dị nnọọ gafere ileocecal junction. Ndị ode akwụkwọ gosipụtara nke a dị ka ọ dị mma megide mgbanwe dị elu nke akọọrọ na nyocha onyonyo ndị ọzọ ebipụtara nke usoro mwepụta egbu oge na-elekwasị anya na eriri afọ..

Nsonaazụ ahụ bụ nkesa, ọ bụghị otu isi. Iri iri na abụọ bụ nsonaazụ siri ike maka ubi, ma ọ ka pụtara nkọwapụta ntọhapụ nke edere megide otu oge aha akọwapụtaghị. Ọ bụrụ na saịtị ebumnuche gị bụ ileum dị anya, nkọwapụta ahụ nwere ịkọwapụta omume anabatara n'ofe nkesa njem - gụnyere ọdụ nke isiokwu ndị na-abịarute n'oge - na nyocha nyocha ga-enwe ike ịmata ọdịiche nke capsule nke meghere n'ebe na-ezighi ezi site na peptide nke mebiri emebi mgbe emepere ya nke ọma.. Rịbakwa ama oke: Nke a bụ ọmụmụ ihe onyonyo iri na abụọ nke otu budesonide, na ọnụ ọgụgụ ya ekwesịghị ibufe ya na mmemme peptide dị ka ọnụego ọganihu a na-atụ anya ya.

Labelụ bụ akụkụ nke nnwale ahụ

Nnwale njem ọ bụla ma ọ bụ biodistribution na peptide chọrọ ụzọ iji hụ ya, na otu ị si hụ ya bụ mgbanwe kemịkalụ. Nhọrọ ndị a na-ahụkarị bụ ihe eji esiji fluorescent, akara redio dị ka 3H, 14C ma ọ bụ 125I, isotopes kwụsiri ike, biotin, na mkpado kemịkalụ dị iche iche. Nke ọ bụla na-ebu profaịlụ mkparị dị iche: nnukwu fluorophore nwere ike ịchịkwa njirimara elu nke obere peptide, akara redio na-anọchi atọm, biotin na-agbakwunye nnukwu ligand hydrophobic-bicyclic nke nwere ike jikọta protein ndị dị ka streptavidin na ebe a na-atụghị anya ya..

Nke microfluidic eriri afọ - mgbochi ọrụ kwuru ihe ize ndụ ahụ ozugbo. N'ihi na ọgụgụ microscope chọrọ onye nta akụkọ fluorescent, na n'ihi na mgbanwe nwere ike gbanwee omume njem nke biologics - karịsịa maka obere peptides - ndị odee na-arụ ụka na ọ bụ ihe kacha mkpa ịhọrọ agba agba nke na-egbochi obere physicochemical Njirimara nke bayoloji., dịka ọmụmaatụ fluorophores egosiri na ha nwere ntakịrị mmasị maka mmekọrịta anụ ahụ lipid. Ha na-ehota ọrụ nke akara fluorophore nke peptide na-abanye cell gbanwere nke ọma na ọnọdụ na ogo nke mmekọrịta biomembrane..

Nke ahụ bụ ihe nlere nha nha nha dị ka mmetụta a na-atụ. Ihe peptide akpọrọ nke na-ejikọta membranes nke ọma karịa nne na nna ya ga-adị ka nke na-agbasawanye n'ụdị cell ma ọ dị obere na nyocha nkwụsi ike nke ìhè., ọnweghịkwa nsonaazụ na-egosipụta mkpụrụ ndụ enweghị akara.

Iwu bara uru: họrọ akara nke na-akpaghasị akụrụngwa ị na-atụ, wee gosi na ụdị aha akpọrọ na nke enweghị aha na-akpa àgwà otu n'ime nyocha nke dị mkpa tupu ị tụkwasị obi na ịgụ akwụkwọ ahụ.. Maka ọmụmụ ihe ike, nke ahụ pụtara iji ụgbọ njem nke akara na peptide enweghị akara n'otu ụdị atụnyere. Maka ọmụmụ nkwụsi ike, ọ pụtara ikwenye akara ngosi anaghị agbanwe profaịlụ mmebi. Maka ọmụmụ ihe ọmụmụ biodistribution, ọ pụtara usoro ọnụọgụ orthogonal - LC-MS/MS nke peptide na-enweghị akara, ọmụmaatụ - megide mgbama onyonyo. Ọ bụrụ na ụdị ndị akpọrọ na ndị na-edeghị aha na-agbanwe, akara bụ nnwale, ọ bụghị peptide.

Ịgụ data: Kedu Assay Zara Ajụjụ

Nnwale peptide ọnụ dara ada na-arụpụta akara, ọ bụghị nchoputa. Tebụl dị n'okpuru maapụ a na-ahụkarị mgbaàmà iji nyocha nke nwere ike kewaa ihe kpatara ha. Ọ bụ usoro mmalite, ọ bụghị osisi mkpebi kwadoro; Ụzọ ndị akọwapụtara na njirisi nnabata bụ nke ngwaahịa gị ma kwesị ekwesị ka a kwado ya megide I Q2(R2) na ogbo mmepe nke gi.

Okwu nyocha dị mkpa ebe a. Ịdị ọcha bụ pasenti mpaghara HPLC na-ekwughị ihe ọ bụla gbasara ole peptide mass dị. Identity bụ nkwenye nhazi orthogonal - mass spectrometry gbakwunyere usoro nke abụọ. Ọdịnaya, ma ọ bụ peptide net, bụ oke nha nha nke na-akpata mgbagha, mmiri na ihe ndị fọdụrụnụ. Peptides dị n'ịntanetị Nkwụsi ike bụ nhazi ọmụmụ nwere ọnọdụ akọwapụtara na oge, ọ bụghị otu nha. Ndabara nke nyocha bụ maka usoro, matrix na njikwa. Otu nọmba ịdị ọcha HPLC enweghị ike ikpebi ọdịda nnyefe, ma na-emeso ya dị ka a ga-asị na ọ nwere ike ịbụ otu n'ime ụzọ ndị a na-emekarị ka mmemme na-eji nkeji anọ na-achụ mgbanwe na-ezighị ezi.

I Q2(R2), nakweere 1 Nọvemba 2023, bụ arịlịka dabara adaba maka akụkụ nyocha. Akụkụ ya kpọmkwem/nhọpụta ya na-akpọ maka data nnọchite anya - chromatograms, electropherogram, spectra - nwere ihe ndị dị mkpa akpọrọ, na maka nyocha nke ịkpa oke kwesịrị ekwesị na ọkwa kwesịrị ekwesị, dị ka mkpebi nke akụkụ abụọ kachasị nso na nkewa dị oke egwu. Nke ahụ bụ ọkọlọtọ usoro nke metụtara nnyefe kwesịrị izute: ọ ga-enwerịrị ike ịhụ ngwaahịa mmebi nke ị na-achọ, ọ bụghị naanị isi elu.

Site na Data Synthesis ruo na Mkpebi Nnyefe

Ndozigharị ahụ kwụ ọtọ ozugbo etinyere ihe mgbochi ahụ n'usoro. Akwụkwọ nyocha, chromatogram, ụdị counterion, solubility na nchịkọta data, na oge nkwụsi ike abụghị ntọhapụ akwụkwọ na-esote mkpọsa njikọ. Ha bụ ntinye na-amachibido nhọrọ ọ bụla ala ala, na a ga-akọwapụta ha na ụzọ nnyefe na-elele site na mmalite.

Usoro a na-arụ ọrụ na-arụ ọrụ dị ka nke a: Ịzụta Peptides

1. Kọwaa saịtị GI ebumnuche yana windo ntọhapụ. Distal ileum, obere eriri afọ proximal, ma ọ bụ afọ na-agbanwe shei, ihe mkpuchi ahụ, na n'echiche n'ụzọ ihe nkọwa nke e dere megide.

2. Nweta nkwụsi ike na permeability chọrọ site na usoro. Chọpụta ebumnuche protease-susceptibility, oxidation-adịkarị mfe resides, ngalaba na-adịkarị mfe nchịkọta, na ụgwọ na profaịlụ hydrophobicity. Ndị a na-edobe kemịlụ nkwụsi ike kacha nta na atụmatụ ikike.

3. Họrọ kemistri nkwụsi ike. Ihe fọdụrụ na-abụghị nke canonical, ịgba ígwè, N-methylation, lipidation, ma ọ bụ ion pairing - nke ọ bụla na-ekwu otu ụgwọ ọrụ akọwapụtara na nzọụkwụ 2, na onye ọ bụla bụ mkpebi nke njikọ ya na nsonaazụ nyocha nke ya. Ụlọ ọrụ Peptides akpọrọ Isotope

4. Họrọ nhazi. Usoro lipid, nkwalite permeation, onye na-egbochi protease, pH modulator. Gosipụta ọnọdụ anụ ahụ peptide n'ime ụgbọ ahụ yana ndakọrịta ya na ihe ndị na-ebupụta ya na ọnọdụ nchekwa echere..

5. Họrọ usoro ntọhapụ. Capsule shei, mkpuchi, ma ọ bụ bilayer architecture, na nkọwapụta ntọhapụ edere megide nkesa njem karịa oge aha.

6. Kọwaa panel nke nyocha nke gosipụtara nzọụkwụ ọ bụla. Mgbasa site na nlele saịtị akọwapụtara, kwụsie ike na-egosi HPLC, nkwenye njirimara orthogonal, ọdịnaya na counterion, na ntụnyere akara-na-enweghị akara maka onyonyo ọ bụla ma ọ bụ ngụgharị njem.

Ịdọ aka ná ntị dị egwu na-amata mgbe mgbanwe usoro na-emebi mkpebi nhazi mbụ. Gbanwee ihe fọdụrụ iji melite ike ma ị nwere ike ịgbanwe ụgwọ ahụ, na mkpokọta propensity, akwụkwọ akụkọ P, ma ọ bụ oxidation ibu - na ion ụzọ, ụgbọ ala lipid, na profaịlụ ntọhapụ capsule nwere ike ọ dị mkpa ka ewepụtaghachi ya ọzọ. Ụdị usoro nke na-adịghị agbanwe agbanwe bụ ihe kacha akpata nsonaazụ nhazi nke enweghị ike imepụtaghachi.. Were usoro na akụkọ mgbanwe ya dị ka ndekọ na-enweghị mgbanwe, ma megharịa ọrụ nhazi ahụ emetụtara mgbe ọ bụla ndekọ ahụ gbanwere.

Nke a bụkwa ebe ọmụmụ GLP-1 nke abụọ na-enweta ọnọdụ ya dị ka ihe nlereanya. Ndị odee enyeghị API emechara n'aka otu nhazi. Ha gbanwere ụdị nnu iji gbanwee nkewa, mụọ ọnọdụ anụ ahụ na ụgbọ ala, achọpụtara ụgwọ oxidation site na usoro, ma wuo capsule gburugburu mkpa nhazi ahụ. Nhazi na nnyefe bụ otu mmemme.

Ebe MOL na-agbanwe dabara

Usoro dị n'elu na-akpọ maka onye mmekọ dị elu nke nwere ike ịmepụta peptide na njirimara njirimara na ụzọ nnyefe nke a na-ele anya.. MOL mgbanwe bụ ụlọ ọrụ nyocha peptide na mmepe mmepe nke na-ekwu na ọ na-enye ọtụtụ ụzọ nyocha ga-ekwe omume maka ọganihu nke sayensị peptide., na ike ya ekwuputara na-esetịpụ na nzọụkwụ mbụ nke usoro ahụ.

Na njikọ, ụlọ ọrụ ahụ na-ekwu na ọ maara nke ọma-phase, mmiri mmiri-phase, jikọtara mmiri mmiri siri ike, ntụgharị siri ike-phase na microbial gbaa ụka ụzọ, na ahaziri usoro ruo 200 amino acid na ọnụ ọgụgụ si milligrams na kilogram. Na mgbanwe, ọ depụtara cycling, stapling, glycosylation, phosphorylation, PEGylation, lipidation, isotope labeling, akara fluorescent na biotinylation n'etiti ihe karịrị 300 mgbanwe otu - kemịkalụ na-apụta na nzọụkwụ 2 na 3 n'elu. Na mma, ọ na-ekwu na a na-edobe mmepụta na klaasị kọwara ndị na-eweta ngwaahịa 100 Ime ụlọ dị ọcha site na nzọụkwụ nnwale mbụ site na nkwakọ ngwaahịa, site na nleba anya nke sterilization na akpaghị aka, ikuku mgbali, iru mmiri, okpomọkụ na uzuzu uzuzu, na QC na-ekpuchi HPLC, MS, ịdị ọcha, ọdịnaya, endotoxin, ịmụ nwa, pH na mmiri nwere data akọwapụtara nke ọma.

Abụọ n'ime onyinye ndị ahụ metụtara nsogbu nha ndị a tụlere na mbụ. Fluorescent na ọrụ ịkpọ aha isotope bụ otu mgbanwe ahụ nwere ike imebi omume njem peptide.; onye mmekọ akara nke na-akọ profaịlụ nyocha ụdị akpọrọ n'akụkụ nne na nna na-enye gị data iji lelee nha anya.. Nhọrọ Counterion bụ lever metụtara - ụlọ ọrụ ahụ depụtara TFA dị ka ndabara, na acetate, chloride ma ọ bụ ammonium nnu mgbanwe dị - ma log P shift na ọmụmụ ihe okpukpu abụọ, site na -2.9 ± 0.3 maka exenatide acetate 0.9 ± 0.2 maka ya DOC ion ụzọ, sitere na ijikọ hydrophobic ion, ọ bụghị site na ụdị mgbanwe nnu ahụ.

Iji doo anya gbasara oke: MOL Mgbanwe na-ekwu ndị a dị ka njikọ nke ya, mgbanwe, ọnụ ọgụgụ na ikike QC. Ọ naghị arụ ọrụ injinia capsule, ọmụmụ ihe onyonyo ma ọ bụ ọrụ ụlọ ọgwụ akọwara na isi mmalite ndị dị n'elu, na ọ dịghị ihe ebe a na-egosi ma ọ bụghị. Njikọ ahụ dị warara ma baa uru karịa - nchịkọta na nhọrọ njirimara nke na-ekpebi ma usoro nnyefe nke ala nwere ebe mmalite nwere ike ịrụ ọrụ na-eme n'oge a., na ha na-mma mere na nnyefe ụzọ ugbua kpọmkwem.

Nkpughe: MOL Mgbanwe bụ njikọ peptide azụmahịa na onye na-eweta mgbanwe ma nwee mmasị azụmahịa na ogo na ụkpụrụ akwụkwọ a tụlere n'isiokwu a..

Ntuziaka na ndetu eweghachi

Eweghachitere isi mmalite 27 October 2026. A na-akọ ọnụ ọgụgụ na nsonaazụ ya n'ogo nke ọmụmụ a e zoro aka na ya na e kwesịghị ịkọwapụta ya na ụmụ irighiri ihe ndị ọzọ., usoro ma ọ bụ ọnụ ọgụgụ ndị ọrịa na-enweghị nkwenye.

• Capsugel® Enprotect® capsules, ibe ngwaahịa, Lonza/Capsugel: https://www.capsugel.com/pharmaceutical-solutions/hard-empty-capsules/enprotect-capsules. Nguzogide acid ruo pH 6.0; enweghị mkpuchi mkpuchi mgbe emejuchara.

• Nchịkọta ihe ọmụma nke Capsugel nke Millet E, Ụlọ ọrụ Vandenbrouke SST, O'Shea JP, Griffin BT, Jannin V. Nleba anya na nhazi usoro nke sistemu capsule bilayer maka nnyefe ọgwụ ụlọ ezubere iche. European Journal of Pharmaceutical Sciences 2026;224:107601. doi:10.1016/j.ejp.2026.107601: https://www.capsugel.com/knowledge-center/pharma/capsules/targeted-ileal-delivery-Enprotect-capsules. Usoro ọmụmụ ihe na usoro; enweghị in vivo absorption kọrọ na nchịkọta.

• Dumont et al. Atụmatụ nchebe nke ọkwa abụọ maka nnyefe ọnụ nke GLP-1 peptides: Nhazi dabere na lipid jikọtara ya na capsules enteric. Oke na nnyefe ọgwụ 2026: https://www.frontiersin.org/articles/10.3389/fddev.2026.1770094/full. In vitro ihe akaebe nke echiche; na vivo PK/PD na nkwụsi ike ogologo oge nke ndị edemede chọpụtara dị ka ọrụ n'ọdịnihu.

• Khalid et al. Nyochaa ihe mgbochi nnyefe peptide ọnụ. Oke na nnyefe ọgwụ 2026: https://www.frontiersin.org/journals/drug-delivery/articles/10.3389/fddev.2026.1809842/full. Onu ogugu bioavailability sub-1% bụ nkwupụta ọkwa nyocha gbasara ọtụtụ ogige, ọ bụghị uru zuru ụwa ọnụ; Ọnụọgụ 21%-47% maka Luna18 bụ nke ziri ezi.

• Nefecon distal-ileum imaging ọmụmụ, PubMed abstract: https://pubmed.ncbi.nlm.nih.gov/38723178/. Ndị ọrụ afọ ofufo iri na abụọ; capsule meghere na distal ileum in 10 na gafere n'ókè nke ileocecal na 2.

• Weller et al. Microfluidic eriri afọ epithelial mgbochi ihe mgbochi. Ọganihu na Bioengineering na Biotechnology 2022;965200: https://www.frontiersin.org/journals/bioengineering-and-biotechnology/articles/10.3389/fbioe.2022.965200/full. Fluorophore perturbation kwuru maka obere peptides.

• Agba aja aja, Whitehead & Mitragotri. Ngwa maka nnyefe ọnụ nke protein na peptides. Ihe nleba anya okike 5:127–148: https://www.nature.com/articles/s41578-019-0156-6. Nyochaa ihe mgbochi physiological.

• I Q2(R2), Nkwado nke usoro nyocha, ikpeazụ version nakweere 1 Nọvemba 2023: https://database.ich.org/sites/default/files/ICH_Q2(R2)_Guideline_2023_1130.pdf.

• I Q1A(R2), Nnwale nkwụsi ike nke ihe ọhụrụ na ngwaahịa ọgwụ, site na FDA: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/q1ar2-stability-testing-new-drug-substances-and-products.

• MOL mgbanwe: saịtị ụlọ ọrụ, omenala peptide njikọ, ule peptide. Ike ụlọ ọrụ kwuru naanị.

Jinling Liu

Usoro R&D na teknụzụ nrụpụta Ọkachamara isi: Nkwalite usoro, onwu onwu, mkpụrụ mma, Nkwekọrịta mmepụta GMP.

Banyere Onye dere ya Ozi kacha ọhụrụ

Profaịlụ: Jinling Liu bụ ọkachamara na ntụgharị usoro ọgwụ peptide sitere na ọnụ ọgụgụ ụlọ nyocha (milligram ọkwa) na mmepụta nke ọnụ ọgụgụ azụmahịa (ọkwa kilogram). O kpebisiri ike ibelata ọnụ ahịa mmepụta peptide nke ọma yana ibelata mmetọ gburugburu ebe obibi site na ịkwalite ọnọdụ mkpochapụ., imeziwanye oke nke reagents condensation, na iwebata teknụzụ njikọ njikọ na-aga n'ihu. Ọ duruwo njikarịcha ọtụtụ ọrụ peptide, na-enweta ọnụ ala dị ala nke ọma, mmepụta oke dị elu dị elu na 100-kilogram.

• Ogo peptide - Jikọọ ịdị ọcha, Ọdịnaya na ntinye nnwale 2026年11月15日
• Mmepụta Peptide GMP - Kọwaa ọrụ dị na nkwekọrịta ogo 2026年11月15日
• Peptides dị arọ omenala - Echiche ise na-ezighị ezi gbasara nkwenye Isotope 2026年11月14日
• Omenala Glycopeptide Synthesis - Ezipụta na Nyochaa Ọdịdị Ọdịdị 2026年11月13日
• Ihe nrịbama nke akpọrọ Peptide dị mma - njikwa maka nkọwa asọmpi 2026年11月13日

Aenyochala eziokwu & Ntuziaka ndezi

Usoro inyocha eziokwu anyị

Anyị na-ebute izi ezi na iguzosi ike n'ezi ihe na ọdịnaya anyị ụzọ. Nke a bụ otu anyị si edobe ụkpụrụ dị elu:

1. Nyocha ọkachamara: Ndị ọkachamara gbasara ihe na-enyocha akụkọ niile.
2. Nkwado isi mmalite: Ekwenyere na-akwado ozi, isi mmalite ọhụrụ.
3. nghọta: Anyị na-ehota n'ụzọ doro anya ma na-ekpughe esemokwu ndị nwere ike ime.

Nyochaa ya bụ: Ndị ọkachamara Okwu

Ụlọ nyocha anyị

Ndị ọkachamara nwere ahụmahụ na-enyocha nke ọma ọdịnaya anyị iji hụ na izi ezi na mkpa.

• Ndị ọkachamara ruru eru: A na-enyocha akụkọ ọ bụla site n'aka ndị ọkachamara nwere ihe ọmụma gbasara mpaghara.
• Ntụle ọhụụ: Anyị na-etinye nyocha kachasị ọhụrụ, usoro, na ụkpụrụ.
• Nkwenye na Ogo: Ndị na-enyocha ihe na-eme ka o doo anya, ziri ezi, na izu oke.

Chọọ akara ndị ọkachamara nyochara ka ị gụọ ọdịnaya ị nwere ike ịtụkwasị obi.